Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin‐activatable fibrinolysis inhibitor
AMMOLLO, C. T., SEMERARO, F., INCAMPO, F., SEMERARO, N., COLUCCI, M.
Published in Journal of thrombosis and haemostasis (01.04.2010)
Published in Journal of thrombosis and haemostasis (01.04.2010)
Get full text
Journal Article
Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin‐independent impairment of the thrombin‐activatable fibrinolysis inhibitor pathway
Colucci, M., Incampo, F., Cannavò, A., Menegatti, M., Siboni, S. M., Zaccaria, F., Semeraro, N., Peyvandi, F.
Published in Journal of thrombosis and haemostasis (01.08.2016)
Published in Journal of thrombosis and haemostasis (01.08.2016)
Get full text
Journal Article
Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI‐mediated inhibition of fibrinolysis
Incampo, F., Carrieri, C., Galasso, R., Scaraggi, F. A., Di Serio, F., Woodhams, B., Semeraro, N., Colucci, M.
Published in Journal of thrombosis and haemostasis (01.02.2013)
Published in Journal of thrombosis and haemostasis (01.02.2013)
Get full text
Journal Article